BCL2 and acute myeloid leukemia: They also found reduced reactive oxygen species (ROS) and Bax (pro-apoptotic) gene expression levels, and increased Ki-67 (nuclear cell proliferation marker) gene and protein levels and Bcl-2 (pro-survival) gene expression in normal BM-MSCs treated with AML-EVs.